Bulk Manufacturer of Controlled Substances Registration, 14913 [2017-05727]
Download as PDF
<![CDATA[
14913
Federal Register / Vol. 82, No. 55 / Thursday, March 23, 2017 / Notices
INTERNATIONAL TRADE
COMMISSION
[USITC SE–17–012]
Government in the Sunshine Act
Meeting Notice
United
States International Trade Commission.
TIME AND DATE: March 30, 2017 at 11:00
a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
AGENCY HOLDING THE MEETING:
Matters To Be Considered
1. Agendas for future meetings: None.
2. Minutes.
3. Ratification List.
4. Vote in Inv. No. 731–TA–1314
(Final) (Phosphor Copper from Korea).
The Commission is currently scheduled
to complete and file its determination
and views of the Commission by April
17, 2017.
5. Outstanding action jackets: None.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
By order of the Commission.
Issued: March 21, 2017.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2017–05893 Filed 3–21–17; 4:15 pm]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturers of various classes of
controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied
to be registered as manufacturers of
various basic classes of controlled
substances. Information on previously
published notices is listed in the table
below. No comments or objections were
submitted for these notices.
SUMMARY:
Company
FR docket
sradovich on DSK3GMQ082PROD with NOTICES
Noramco, Inc .................................................................................................................................................
Isosciences ....................................................................................................................................................
AMRI Rensselaer, Inc ...................................................................................................................................
Halo Pharmaceutical, Inc ..............................................................................................................................
AMPAC Fine Chemicals LLC ........................................................................................................................
Insys Manufacturing LLC ..............................................................................................................................
Patheon API Manufacturing, Inc ...................................................................................................................
Euticals Inc ....................................................................................................................................................
Nanosyn, Inc .................................................................................................................................................
Cerilliant Corporation .....................................................................................................................................
Research Triangle Institute ...........................................................................................................................
Synthcon LLC ................................................................................................................................................
Navinta LLC ...................................................................................................................................................
Johnson Matthey, Inc ....................................................................................................................................
AMRI Rensselaer, Inc ...................................................................................................................................
Cayman Chemical Company ........................................................................................................................
Cambridge Isotope Laboratories ...................................................................................................................
Janssen Pharmaceutical, Inc ........................................................................................................................
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
VerDate Sep<11>2014
17:13 Mar 22, 2017
Jkt 241001
Notice of registration.
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed persons.
81
81
81
81
81
81
81
81
81
81
81
81
81
81
81
81
81
81
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
57936
61249
61250
63220
63222
63221
64509
64510
64949
66079
91948
95641
95640
95647
95639
95644
95644
96045
Published
August 24, 2016.
September 6, 2016.
September 6, 2016.
September 14, 2016.
September 14, 2016.
September 14, 2016.
September 20, 2016.
September 20, 2016.
September 21, 2016.
September 26, 2016.
December 19, 2016.
December 28, 2016.
December 28, 2016.
December 28, 2016.
December 28, 2016.
December 28, 2016.
December 28, 2016.
December 29, 2016.
Dated: March 17, 2017.
Louis J. Milione,
Assistant Administrator.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
[FR Doc. 2017–05727 Filed 3–22–17; 8:45 am]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
PO 00000
SUMMARY:
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
Notice of registration.
Frm 00049
Fmt 4703
Sfmt 4703
E:\FR\FM\23MRN1.SGM
23MRN1
]]>Agencies
[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)]
[Notices]
[Page 14913]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05727]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as bulk
manufacturers of various classes of controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as
manufacturers of various basic classes of controlled substances.
Information on previously published notices is listed in the table
below. No comments or objections were submitted for these notices.
----------------------------------------------------------------------------------------------------------------
Company FR docket Published
----------------------------------------------------------------------------------------------------------------
Noramco, Inc............................. 81 FR 57936 August 24, 2016.
Isosciences.............................. 81 FR 61249 September 6, 2016.
AMRI Rensselaer, Inc..................... 81 FR 61250 September 6, 2016.
Halo Pharmaceutical, Inc................. 81 FR 63220 September 14, 2016.
AMPAC Fine Chemicals LLC................. 81 FR 63222 September 14, 2016.
Insys Manufacturing LLC.................. 81 FR 63221 September 14, 2016.
Patheon API Manufacturing, Inc........... 81 FR 64509 September 20, 2016.
Euticals Inc............................. 81 FR 64510 September 20, 2016.
Nanosyn, Inc............................. 81 FR 64949 September 21, 2016.
Cerilliant Corporation................... 81 FR 66079 September 26, 2016.
Research Triangle Institute.............. 81 FR 91948 December 19, 2016.
Synthcon LLC............................. 81 FR 95641 December 28, 2016.
Navinta LLC.............................. 81 FR 95640 December 28, 2016.
Johnson Matthey, Inc..................... 81 FR 95647 December 28, 2016.
AMRI Rensselaer, Inc..................... 81 FR 95639 December 28, 2016.
Cayman Chemical Company.................. 81 FR 95644 December 28, 2016.
Cambridge Isotope Laboratories........... 81 FR 95644 December 28, 2016.
Janssen Pharmaceutical, Inc.............. 81 FR 96045 December 29, 2016.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of these registrants to manufacture
the applicable basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each of the company's maintenance of
effective controls against diversion by inspecting and testing each
company's physical security systems, verifying each company's
compliance with state and local laws, and reviewing each company's
background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed persons.
Dated: March 17, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-05727 Filed 3-22-17; 8:45 am]
BILLING CODE 4410-09-P
